Clinical Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium Infection and Cancer: Biology, Therapeutics, and Prevention
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chawla-Sarkar, M.
Right arrow Articles by Borden, E. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chawla-Sarkar, M.
Right arrow Articles by Borden, E. C.
Clinical Cancer Research Vol. 7, 1821-1831, June 2001
© 2001 American Association for Cancer Research

Regular Articles

Preferential Induction of Apoptosis by Interferon (IFN)-ß Compared with IFN-{alpha}2

Correlation with TRAIL/Apo2L Induction in Melanoma Cell Lines

Mamta Chawla-Sarkar1, Douglas W. Leaman1 and Ernest C. Borden2

Center for Drug Discovery and Development, Taussig Cancer Center and Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, Ohio 44195

On the basis of in vitro inhibition of tumor cell growth, IFNs have been generally considered to be antiproliferative proteins. To probe further the potential mechanisms of the antitumor effects of IFNs, we have assessed apoptosis in response to IFN-{alpha}2 and IFN-ß in cell lines of varied histologies, with a focus on melanomas. Many of the cell lines tested underwent apoptosis in response to IFN-ß, as assessed both by Annexin V and terminal deoxynucleotidyl transferase-mediated nick end labeling staining. In general, IFN-ß had greater growth inhibitory and proapoptotic effects than IFN-{alpha}2 on all cell lines. The melanoma cell line WM9, sensitive to growth inhibition by IFNs, had a greater degree of apoptosis than A375 melanoma cells, which were largely resistant to antigrowth effects of IFNs. IFN-ß-induced apoptosis was dependent on activation of the caspase cascade with cleavage of caspases 3, 8, and 9 and of the caspase 3 substrate, poly(ADP-ribose) polymerase. Caspase inhibitors benzyloxycarbonyl-Val-Ala-Asp-fluoromethyl keton or benzyloxycarbonyl-Asp-Glu-Val-Asp-fluoromethyl keton, inhibited IFN-ß-induced apoptosis. Other changes associated with apoptosis, including the movement of cytochrome c from mitochondria to cytoplasm and DNA fragmentation, were also identified in response to IFN-ß. Apo2L ligand [tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)] was one of the early genes induced by IFN-ß in apoptosis-sensitive WM9 cells. Other sensitive melanoma cell lines had a similar IFN-ß-specific induction of TRAIL. Neutralizing antibody to TRAIL inhibited IFN-ß-induced apoptosis in WM9 cells. In resistant A375 cells, IFN-ß did not induce TRAIL/Apo2L expression. Thus, induction of TRAIL by IFNs in some tumor types may initiate the apoptotic cascade. This study offers another mechanism for the antitumor effects of IFNs.




This article has been cited by other articles:


Home page
 Cancer Res.Home page
G. B. Lesinski, E. T. Raig, K. Guenterberg, L. Brown, M. R. Go, N. N. Shah, A. Lewis, M. Quimper, E. Hade, G. Young, et al.
IFN-{alpha} and Bortezomib Overcome Bcl-2 and Mcl-1 Overexpression in Melanoma Cells by Stimulating the Extrinsic Pathway of Apoptosis
Cancer Res., October 15, 2008; 68(20): 8351 - 8360.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
E. Kalie, D. A. Jaitin, R. Abramovich, and G. Schreiber
An Interferon {alpha}2 Mutant Optimized by Phage Display for IFNAR1 Binding Confers Specifically Enhanced Antitumor Activities
J. Biol. Chem., April 13, 2007; 282(15): 11602 - 11611.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
F. J. Reu, S. I. Bae, L. Cherkassky, D. W. Leaman, D. Lindner, N. Beaulieu, A. R. MacLeod, and E. C. Borden
Overcoming Resistance to Interferon-Induced Apoptosis of Renal Carcinoma and Melanoma Cells by DNA Demethylation
J. Clin. Oncol., August 10, 2006; 24(23): 3771 - 3779.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
F. J. Reu, D. W. Leaman, R. R. Maitra, S. I. Bae, L. Cherkassky, M. W. Fox, D. R. Rempinski, N. Beaulieu, A. R. MacLeod, and E. C. Borden
Expression of RASSF1A, an Epigenetically Silenced Tumor Suppressor, Overcomes Resistance to Apoptosis Induction by Interferons.
Cancer Res., March 1, 2006; 66(5): 2785 - 2793.
[Abstract] [Full Text] [PDF]

Home page
 Mult SclerHome page
F Gilli, F Marnetto, M Caldano, A Sala, S Malucchi, M Capobianco, and A Bertolotto
Biological markers of interferon-beta therapy: comparison among interferon-stimulated genes MxA, TRAIL and XAF-1
Multiple Sclerosis, February 1, 2006; 12(1): 47 - 57.
[Abstract] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
A. Schwarting, K. Paul, S. Tschirner, J. Menke, T. Hansen, W. Brenner, V. R. Kelley, M. Relle, and P. R. Galle
Interferon-{beta}: A Therapeutic for Autoimmune Lupus in MRL-Faslpr Mice
J. Am. Soc. Nephrol., November 1, 2005; 16(11): 3264 - 3272.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
G. Hu, M. E. Mancl, and B. J. Barnes
Signaling through IFN Regulatory Factor-5 Sensitizes p53-Deficient Tumors to DNA Damage-Induced Apoptosis and Cell Death
Cancer Res., August 15, 2005; 65(16): 7403 - 7412.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Y. Sun and D. W. Leaman
Involvement of Noxa in Cellular Apoptotic Responses to Interferon, Double-stranded RNA, and Virus Infection
J. Biol. Chem., April 22, 2005; 280(16): 15561 - 15568.
[Abstract] [Full Text] [PDF]

Home page
 Hum Reprod UpdateHome page
M. R. Hussein
Apoptosis in the ovary: molecular mechanisms
Hum. Reprod. Update, March 1, 2005; 11(2): 162 - 178.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. Papageorgiou, L. Lashinger, R. Millikan, H. B. Grossman, W. Benedict, C. P. N. Dinney, and D. J. McConkey
Role of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand in Interferon-Induced Apoptosis in Human Bladder Cancer Cells
Cancer Res., December 15, 2004; 64(24): 8973 - 8979.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
M. Studeny, F. C. Marini, J. L. Dembinski, C. Zompetta, M. Cabreira-Hansen, B. N. Bekele, R. E. Champlin, and M. Andreeff
Mesenchymal Stem Cells: Potential Precursors for Tumor Stroma and Targeted-Delivery Vehicles for Anticancer Agents
J Natl Cancer Inst, November 3, 2004; 96(21): 1593 - 1603.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
B. Damdinsuren, H. Nagano, M. Sakon, M. Kondo, T. Yamamoto, K. Umeshita, K. Dono, S. Nakamori, and M. Monden
Interferon-{beta} Is More Potent Than Interferon-{alpha} in Inhibition of Human Hepatocellular Carcinoma Cell Growth When Used Alone and in Combination With Anticancer Drugs
Ann. Surg. Oncol., December 1, 2003; 10(10): 1184 - 1190.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
R. Deonarain, A. Verma, A. C. G. Porter, D. R. Gewert, L. C. Platanias, and E. N. Fish
Critical roles for IFN-{beta} in lymphoid development, myelopoiesis, and tumor development: Links to tumor necrosis factor {alpha}
PNAS, November 11, 2003; 100(23): 13453 - 13458.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Chawla-Sarkar, J. A. Bauer, J. A. Lupica, B. H. Morrison, Z. Tang, R. K. Oates, A. Almasan, J. A. DiDonato, E. C. Borden, and D. J. Lindner
Suppression of NF-{kappa}B Survival Signaling by Nitrosylcobalamin Sensitizes Neoplasms to the Anti-tumor Effects of Apo2L/TRAIL
J. Biol. Chem., October 10, 2003; 278(41): 39461 - 39469.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Y. Honma, Y. Ishii, Y. Yamamoto-Yamaguchi, T. Sassa, and K.-i. Asahi
Cotylenin A, a Differentiation-inducing Agent, and IFN-{alpha} Cooperatively Induce Apoptosis and Have an Antitumor Effect on Human Non-Small Cell Lung Carcinoma Cells in Nude Mice
Cancer Res., July 1, 2003; 63(13): 3659 - 3666.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
S. M. Altmann, M. T. Mellon, D. L. Distel, and C. H. Kim
Molecular and Functional Analysis of an Interferon Gene from the Zebrafish, Danio rerio
J. Virol., February 1, 2003; 77(3): 1992 - 2002.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
D. W. Leaman, M. Chawla-Sarkar, K. Vyas, M. Reheman, K. Tamai, S. Toji, and E. C. Borden
Identification of X-linked Inhibitor of Apoptosis-associated Factor-1 as an Interferon-stimulated Gene That Augments TRAIL Apo2L-induced Apoptosis
J. Biol. Chem., August 2, 2002; 277(32): 28504 - 28511.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
Y. E. Chang, L. Pena, G. C. Sen, J. K. Park, and L. A. Laimins
Long-Term Effect of Interferon on Keratinocytes That Maintain Human Papillomavirus Type 31
J. Virol., July 29, 2002; 76(17): 8864 - 8874.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. Chawla-Sarkar, D. W. Leaman, B. S. Jacobs, and E. C. Borden
IFN-{beta} Pretreatment Sensitizes Human Melanoma Cells to TRAIL/Apo2 Ligand-Induced Apoptosis
J. Immunol., July 15, 2002; 169(2): 847 - 855.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
M. S. Chacko, X. Ma, and M. L. Adamo
Double-Stranded Ribonucleic Acid Decreases C6 Rat Glioma Cell Proliferation in Part by Activating Protein Kinase R and Decreasing Insulin-Like Growth Factor I Levels
Endocrinology, June 1, 2002; 143(6): 2144 - 2154.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C. Kumar-Sinha, S. Varambally, A. Sreekumar, and A. M. Chinnaiyan
Molecular Cross-talk between the TRAIL and Interferon Signaling Pathways
J. Biol. Chem., January 4, 2002; 277(1): 575 - 585.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
R. H. Silverman, A. Halloum, A. Zhou, B. Dong, F. Al-Zoghaibi, D. Kushner, Q. Zhou, J. Zhao, T. Wiedmer, and P. J. Sims
Suppression of Ovarian Carcinoma Cell Growth in Vivo by the Interferon-inducible Plasma Membrane Protein, Phospholipid Scramblase 1
Cancer Res., January 1, 2002; 62(2): 397 - 402.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
J. Van Weyenbergh, J. Wietzerbin, D. Rouillard, M. Barral-Netto, and R. Liblau
Treatment of multiple sclerosis patients with interferon-{beta} primes monocyte-derived macrophages for apoptotic cell death
J. Leukoc. Biol., November 1, 2001; 70(5): 745 - 748.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2001 by the American Association for Cancer Research.